State Systems Development Initiative Grant Program
Deadline: Sept. 2
This announcement solicits applications for the State Systems Development Initiative (SSDI) Grant Program. The purpose of SSDI is to develop, enhance and expand State Title V MCH data capacity to allow for informed decision making and resource allocation that supports effective, efficient and quality programming for women, infants, children and youth, including children and youth with special health care needs. Applicants should note the purpose of SSDI was modified from previous grant cycles to reflect its alignment with efforts in the HRSA, MCH Services Block Grant to States program. These efforts seek to ensure the continued effectiveness and readiness of Title V-supported programs in responding to the changing needs of the nation's MCH population. For more information, click here.
NIH Obstetric-Fetal Pharmacology Research Centers
Deadline: Sept. 15
The purpose of this FOA is to announce the competition of the Obstetric-Fetal Pharmacology Research Centers (OPRC) - a specialized cooperative multicenter program in the obstetric pharmacology research. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) proposes to fund a limited number of research centers which will provide an arena for multidisciplinary interactions among basic and clinical scientists interested in establishing high quality translational research programs in the area of obstetric pharmacology. The centers will also serve as national resources for clinical pharmacological research in women during normal and abnormal pregnancies. Center investigators will be expected to work with NICHD staff in facilitating research collaborations and interactions within and among the centers. Such a cooperative program will form a national network that facilitates the translation of knowledge from the basic sciences into the development of new treatments, and findings from clinical studies/trials into practice with ultimate goal of improving the safety and effectiveness of the medical treatment in pregnant women. To learn more, click here.
NIH Interventions for Youth Who Misuse/Abuse Prescription Stimulant Medications
Deadline: Nov. 13
This FOA solicits U01 applications conducting either hypothesis-driven or hypothesis-generating controlled research to build an evidence base to address the problem of prescription stimulant medication (PSM) misuse in youth. Specifically this FOA solicits research applications that develop and test the efficacy of interventions to either prevent or reduce the misuse and diversion of PSMs among high school students and/or college students. Animal studies and epidemiological research will be considered unresponsive. For more information, click here.
NIH Initiative to Maximize Research Education in Genomics Diversity Action Plan
Deadline: Sept. 6, 2016
The National Institutes of Health (NIH) present this funding opportunity to facilitate the training of individuals at all careers levels (the undergraduate, graduate, post baccalaureate, postdoctoral and faculty levels) from diverse backgrounds underrepresented in scientific disciplines relevant to genomics to enable them to pursue genomics research that spans all areas of interest to National Human Genome Research Institute later in their careers. To learn more, click here.
Exploratory and Developmental Grant to Improve Health Care Quality through Health IT
Deadline: Nov. 16, 2016
The purpose of this grant is to fund exploratory and developmental research grants that will contribute to the evidence base of how health information technology (IT) improves health care quality. This funding opportunity supports the use of a wide variety of research designs in order to generate information regarding the design and development, implementation, use, or impact of health IT on quality. For more information on grant PA-14-001 and more, click here.